Why is Alkem Lab falling/rising?

As of 04-Sep, Alkem Laboratories Ltd is experiencing a slight decline in its stock price, currently at 5,300.95, reflecting a change of -0.65, or -0.01%. The stock's performance today is in line with its sector, although it is trading higher than the 20-day, 50-day, 100-day, and 200-day moving averages, but lower than the 5-day moving average. Notably, there has been a significant drop in investor participation, with delivery volume falling by 44.54% against the 5-day average. Over the past week, the stock has decreased by 1.09%, while it has shown a positive return of 8.05% over the past month. Despite a year-to-date decline of 5.85% and a one-year return of -14.51%, the company's profits have increased by 4.9%, indicating some underlying strength. The stock is viewed as fairly valued with a Price to Book Value of 5.3 and a high return on equity (ROE) of 17.69%, which suggests management efficiency and a low debt-to-equity ratio.
In the broader market context, the Sensex has increased by 0.80% over the past week, contrasting with Alkem's decline. While the stock has underperformed relative to the benchmark in the short term, it has outperformed over the last three years with a return of 78.29% compared to the Sensex's 37.27%. The current liquidity of the stock remains adequate for trading, but the falling investor participation may indicate a cautious sentiment among investors. Overall, while Alkem Laboratories Ltd has some positive attributes, the recent decline in stock price reflects a combination of lower investor engagement and underperformance against the benchmark in the short term.